Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma
- PMID: 2746048
- DOI: 10.1007/BF02925701
Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma
Abstract
The expression of the gastrointestinal cancer-associated antigens CA 19-9 and CA-50 was studied in 43 ductal pancreatic carcinomas, 1 mucinous cystadenoma, 1 signet-ring-cell carcinoma, 42 pancreata with chronic pancreatitis, and 10 normal fetal and adult pancreata. The anti-CA-50 antibody gave a more intense and more uniformly distributed staining of the ductal epithelial cells than the anti-CA 19-9 antibody. Both antigens, however, exhibited the same staining pattern of ductal epithelial cells in normal pancreas and chronic pancreatitis. Well differentiated carcinomas showed a predominantly membrane-bound antigen expression, whereas moderately and poorly differentiated carcinomas gave a more diffuse cytoplasmic staining. Epithelial dysplasia could not be differentiated by the staining pattern from normal, hyperplastic, metaplastic, or neoplastic cells. The immunohistochemical reaction with these anticarbohydrate antibodies, therefore, does not allow a qualitative discrimination between chronic pancreatitis and pancreatic carcinoma. CA 19-9, which expression depends on the Lewis gene, was negative in two patients with Le(a-b-) phenotype. Although anti-CA-50 antibody was reactive with the cancer cells of these 2 patients, the staining was weak and heterogenous.
Similar articles
-
Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.Virchows Arch A Pathol Anat Histopathol. 1989;414(6):465-76. doi: 10.1007/BF00781703. Virchows Arch A Pathol Anat Histopathol. 1989. PMID: 2499104
-
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.Br J Cancer. 1989 Dec;60(6):845-51. doi: 10.1038/bjc.1989.377. Br J Cancer. 1989. PMID: 2557879 Free PMC article.
-
Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.Br J Cancer. 1986 Feb;53(2):189-95. doi: 10.1038/bjc.1986.34. Br J Cancer. 1986. PMID: 3513813 Free PMC article.
-
Lex and Ley antigen expression in human pancreatic cancer.Cancer Res. 1988 Jan 15;48(2):475-82. Cancer Res. 1988. PMID: 3335015
-
Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.Int J Cancer. 1986 Dec 15;38(6):841-6. doi: 10.1002/ijc.2910380610. Int J Cancer. 1986. PMID: 3466871
Cited by
-
Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature.Cancer Immunol Immunother. 2020 Sep;69(9):1823-1832. doi: 10.1007/s00262-020-02587-8. Epub 2020 Apr 29. Cancer Immunol Immunother. 2020. PMID: 32350591 Free PMC article.
-
Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status.Br J Cancer. 1990 Jul;62(1):118-21. doi: 10.1038/bjc.1990.241. Br J Cancer. 1990. PMID: 2390470 Free PMC article.
-
Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.Mol Imaging Biol. 2020 Dec;22(6):1511-1522. doi: 10.1007/s11307-020-01522-8. Epub 2020 Aug 11. Mol Imaging Biol. 2020. PMID: 32780212 Free PMC article.
-
Circulating blood group related carbohydrate antigens as tumour markers.Glycoconj J. 1995 Jun;12(3):200-5. doi: 10.1007/BF00731320. Glycoconj J. 1995. PMID: 7496132 Review.
-
Discovery and 3D imaging of a novel ΔNp63-expressing basal cell type in human pancreatic ducts with implications in disease.Gut. 2021 Jul 30;71(10):2030-42. doi: 10.1136/gutjnl-2020-322874. Online ahead of print. Gut. 2021. PMID: 34330784 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical